Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Qianyuan Hailisheng Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, production, and marketing of natural marine drugs, natural mineral drugs, and chemically synthesized pharmaceuticals. Originally established in 1989 as Putuo Mountain Pharmaceutical Factory and later known as Zhejiang Hailisheng Pharmaceutical, the company became a subsidiary of Shanxi Qianyuan Pharmaceutical Group in 2012. Its commercial portfolio includes key products such as Beiteling (Vitamin AD drops), Telin (glucosamine indomethacin sustained-release capsules), Qisuo (tamsulosin hydrochloride sustained-release capsules), and Kenteling (montmorillonite powder). The company operates advanced manufacturing facilities certified under GMP standards, producing a wide range of formulations including soft capsules, tablets, injections, and active pharmaceutical ingredients (APIs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Qianyuan Hailisheng Pharmaceutical.